Search Results - Dominique Larrey
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
-
5
-
6
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)... by Jean‐Pierre Bronowicki, Patrick Miailhes, Bertrand Hanslik, Denis Ouzan, Dominique Larrey, Ghassan Riachi, Régine Truchi, Vincent Jouannaud, Dan Pospait, Armand Abergel, Xavier Causse, Stéphanie Perot, Jérémy Skrzypski, Astrid De Hautecloque, Axelle Spampinato, Philippe Mariot, Philippe Sogni, the Zephyr Study group
Published in Health Science Reports (2023-01-01)Get full text
Article -
7
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort by Tangui Barré, Fabrice Carrat, Clémence Ramier, Hélène Fontaine, Vincent Di Beo, Morgane Bureau, Céline Dorival, Dominique Larrey, Elisabeth Delarocque-Astagneau, Philippe Mathurin, Fabienne Marcellin, Ventzislava Petrov-Sanchez, Carole Cagnot, Patrizia Carrieri, Stanislas Pol, Camelia Protopopescu, the ANRS/AFEF Hepather study group
Published in Journal of Cannabis Research (2022-06-01)Get full text
Article -
8
The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance by Patricia Aguilar-Martinez, Michael Bismuth, François Blanc, Pierre Blanc, Severine Cunat, Olivier Dereure, Pierre Dujols, Muriel Giansily-Blaizot, Christian Jorgensen, Amadou Konate, Dominique Larrey, Alain Le Quellec, Thibault Mura, Isabelle Raingeard, Jeanne Ramos, Eric Renard, Florence Rousseau, Jean-François Schved, Marie-Christine Picot
Published in Haematologica (2010-04-01)Get full text
Article -
9
Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort) by Tangui Barré, Hélène Fontaine, Stanislas Pol, Clémence Ramier, Vincent Di Beo, Camelia Protopopescu, Fabienne Marcellin, Morgane Bureau, Marc Bourlière, Céline Dorival, Ventzislava Petrov-Sanchez, Tarik Asselah, Elisabeth Delarocque-Astagneau, Dominique Larrey, Jean-Charles Duclos-Vallée, Fabrice Carrat, Patrizia Carrieri, on behalf of the ANRS/AFEF Hepather Study Group
Published in Antioxidants (2022-02-01)Get full text
Article -
10
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort by Lina Hountondji, Christophe Ferreira De Matos, Fanny Lebossé, Xavier Quantin, Candice Lesage, Pascale Palassin, Valérian Rivet, Stéphanie Faure, Georges-Philippe Pageaux, Éric Assenat, Laurent Alric, Amel Zahhaf, Dominique Larrey, Philine Witkowski Durand Viel, Benjamin Riviere, Selves Janick, Stéphane Dalle, Alexandre Thibault Jacques Maria, Thibaut Comont, Lucy Meunier
Published in JHEP Reports (2023-06-01)Get full text
Article -
11
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the... by Frédégonde About, Tiphaine Oudot-Mellakh, Jonathan Niay, Pascaline Rabiéga, Vincent Pedergnana, Darragh Duffy, Philippe Sultanik, Carole Cagnot, Fabrice Carrat, Patrick Marcellin, Fabien Zoulim, Dominique Larrey, Christophe Hézode, Hélène Fontaine, Jean-Pierre Bronowicki, Stanislas Pol, Matthew L Albert, Ioannis Theodorou, Aurélie Cobat, Laurent Abel, ANRS CO20-CUPIC study group
Published in PLoS ONE (2015-01-01)Get full text
Article
